Last reviewed · How we verify
Lamivudine, Zidovudine and nevirapine
Lamivudine, Zidovudine and nevirapine is a Small molecule drug developed by Elim Pediatric Pharmaceuticals Inc.. It is currently in Phase 1 development. Also known as: Lamivudine, Zidovudine, Nevirapine.
At a glance
| Generic name | Lamivudine, Zidovudine and nevirapine |
|---|---|
| Also known as | Lamivudine, Zidovudine, Nevirapine |
| Sponsor | Elim Pediatric Pharmaceuticals Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV (PHASE2, PHASE3)
- A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments (PHASE4)
- Early Infant HIV Treatment in Botswana (PHASE2, PHASE3)
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (PHASE2, PHASE3)
- Research on the Psychological Status of Patients With HIV-1 Infection
- A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding (PHASE2)
- A Prospective Cohort of Children With HIV Infection
- ARVs to Prevent Breastmilk HIV:Viral and Immune Responses (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lamivudine, Zidovudine and nevirapine CI brief — competitive landscape report
- Lamivudine, Zidovudine and nevirapine updates RSS · CI watch RSS
- Elim Pediatric Pharmaceuticals Inc. portfolio CI
Frequently asked questions about Lamivudine, Zidovudine and nevirapine
What is Lamivudine, Zidovudine and nevirapine?
Lamivudine, Zidovudine and nevirapine is a Small molecule drug developed by Elim Pediatric Pharmaceuticals Inc..
Who makes Lamivudine, Zidovudine and nevirapine?
Lamivudine, Zidovudine and nevirapine is developed by Elim Pediatric Pharmaceuticals Inc. (see full Elim Pediatric Pharmaceuticals Inc. pipeline at /company/elim-pediatric-pharmaceuticals-inc).
Is Lamivudine, Zidovudine and nevirapine also known as anything else?
Lamivudine, Zidovudine and nevirapine is also known as Lamivudine, Zidovudine, Nevirapine.
What development phase is Lamivudine, Zidovudine and nevirapine in?
Lamivudine, Zidovudine and nevirapine is in Phase 1.
Related
- Manufacturer: Elim Pediatric Pharmaceuticals Inc. — full pipeline
- Also known as: Lamivudine, Zidovudine, Nevirapine
- Compare: Lamivudine, Zidovudine and nevirapine vs similar drugs
- Pricing: Lamivudine, Zidovudine and nevirapine cost, discount & access